Author profile picture

The Eindhoven startup Salvia BioElectronics B.V. has received additional investment from the Brabant Startup Fund (BSF), bringing the total seed funding to €3.1 million. The startup already received investment from the Brabant Development Agency (BOM) and Thuja Capital, which is complemented with a loan from the Netherlands Enterprise Agency (RVO). At the High Tech Campus Eindhoven, Salvia develops a minimally invasive bioelectronics solution for people suffering from chronic neurological disease.

Hubert Martens, CEO of Salvia BioElectronics, noted: “We are very pleased to attract this additional funding that allows us to further mature our technology before initiating the product development phase. This will translate in a substantial acceleration of the product development phase after the upcoming series-A funding round.” Gerard Spanbroek, director of the Brabant Startup Funded added: “The BSF supports early-stage innovative companies with a strong growth potential. We are keen on supporting Salvia towards their next growth phase. We are impressed by the progress that this experienced team realized in a short amount of time and see significant potential health benefits of their novel product concept.”

Read more about Salvia BioElectronics here